Back to User profile » Professor Yuzhen Liang
Papers published by Professor Yuzhen Liang:
GLP-1RA Liraglutide and Semaglutide Improves Obesity-Induced Muscle Atrophy via SIRT1 Pathway
Xiang J, Qin L, Zhong J, Xia N, Liang Y
Diabetes, Metabolic Syndrome and Obesity 2023, 16:2433-2446
Published Date: 15 August 2023
Guava Leaf Extract Attenuates Insulin Resistance via the PI3K/Akt Signaling Pathway in a Type 2 Diabetic Mouse Model
Yang Q, Wen YM, Shen J, Chen MM, Wen JH, Li ZM, Liang YZ, Xia N
Diabetes, Metabolic Syndrome and Obesity 2020, 13:713-718
Published Date: 13 March 2020
Liraglutide Improves Non-Alcoholic Fatty Liver Disease In Diabetic Mice By Modulating Inflammatory Signaling Pathways
Luo Y, Yang P, Li Z, Luo Y, Shen J, Li R, Zheng H, Liang Y, Xia N
Drug Design, Development and Therapy 2019, 13:4065-4074
Published Date: 2 December 2019
Effects of liraglutide on lipolysis and the AC3/PKA/HSL pathway
Li Z, Yang P, Liang Y, Xia N, Li Y, Su H, Pan H
Diabetes, Metabolic Syndrome and Obesity 2019, 12:1697-1703
Published Date: 3 September 2019
Liraglutide ameliorates nonalcoholic fatty liver disease in diabetic mice via the IRS2/PI3K/Akt signaling pathway
Yang P, Liang Y, Luo Y, Li Z, Wen Y, Shen J, Li R, Zheng H, Gu HF, Xia N
Diabetes, Metabolic Syndrome and Obesity 2019, 12:1013-1021
Published Date: 4 July 2019
Prevalence of abnormal glucose homeostasis in Chinese patients with non-transfusion-dependent thalassemia
Luo Y, Bajoria R, Lai Y, Pan H, Li Q, Zhang Z, Yang P, Chatterjee R, Liang Y
Diabetes, Metabolic Syndrome and Obesity 2019, 12:457-468
Published Date: 11 April 2019